S Alice Longa & Cate Speake comment on:
#IL-2 and immunoregulatory therapies in newly diagnosed type 1 #diabetes thelancet.com/journals/lan...
#T1D
#EASD2026

“Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults.”
Publié ce jour dans le @nejm.org.
#MedSky #EndoSky
www.nejm.org/doi/full/10....
New—Diabetes and the role of primary care: a global perspective thelancet.com/journals/lan...
#diabetes
#EASD2026
Published in @thelancet.com
#Retatrutide in adults with #obesity and type 2 #diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial www.thelancet.com/journals/lan...
#T2D
#EASD2026
Shukri F Mohameda & Andre Pascal Kengne comment on:
What #Mauritius teaches us about #diabetes surveillance thelancet.com/journals/lan...
#T2D #OGTT
#FREE to read w/reg (also FREE)
#EASD2026
New—Trends in prevalence of type 2 #diabetes and intermediate #hyperglycaemia in #Mauritius from 1987 to 2021 based on results from the oral glucose tolerance test: a repeated cross-sectional study thelancet.com/journals/lan...
#T2D #OGTT
#FREE to read w/reg (also FREE)
#EASD2026
New Editorial:
Safeguarding paediatric metabolic health www.thelancet.com/journals/lan...
#obesity
#FREE to read
The ATA has discouraged the use of T3 for depression. The risks of a suppressed TSH are well known.
But the suggestion to use a brain-selective T3 analog in chronically depressed patients? That may have some merit.
Thyroid, August 2026
Sten Madsbad & Jens J Holst comment on:
Petrelintide and the evolving role of amylin agonism in obesity thelancet.com/journals/lan...
#obesity
#EASD2026
New—Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial thelancet.com/journals/lan...
#obesity
#EASD2026
Also read the original TimeCapsule article:
A quarter-century of progress: innovations in lipid medicine that transformed cardiovascular prevention thelancet.com/journals/lan...
#LDL #cholesterol #ASCVD #statins #PCSK9 inhibitors
25 Years of Lipid Medicine youtube.com/watch?v=atCH...
#LDL #cholesterol #ASCVD
#statins #PCSK9 inhibitors
#Semaglutide was effective in decreasing #CKD progression regardless of the administration route or indication (type 2 #diabetes or #obesity), adding to the evidence provided by FLOW in people with type 2 diabetes & CKD www.thelancet.com/journals/lan...
#T2D
Published in @ebiomedicine.bsky.social
Metabolomic profiling of ultra-processed food consumption and #cardiovascular risk in Spanish preschool children: a cross-sectional study www.thelancet.com/journals/ebi...
#UPFs #CVD
#OpenAccess
Published in @lancetrh-europe.bsky.social
Prenatal high-dose vitamin D supplementation and offspring bone mineral content and density at age 13 years: a secondary analysis of a randomised clinical trial www.thelancet.com/journals/lan...
#VitaminD #BoneHealth
#OpenAccess
Published in @eclinicalmed.bsky.social
Overnight metyrapone in mild autonomous cortisol secretion: a single-centre, single-arm, phase 2 trial www.thelancet.com/journals/ecl...
#OpenAccess
Examine the pathophysiology, clinical presentation, diagnostic approach, and neuroimaging features for infiltrative and inflammatory disorders involving the pituitary gland, with strategies to aid recognition and management.